# StemoniX, Inc.: Form D filings

StemoniX, Inc., a biotechnology company in Maple Grove, MN, filed 10 Form D notices with the SEC between 2016 and 2020. The latest, on May 15, 2020, reports $100,000 sold of a $10.9 million offering to 3 investors.

Find out what StemoniX, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20StemoniX%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=StemoniX%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fstemonix-inc-1663434)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20StemoniX%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=StemoniX%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fstemonix-inc-1663434)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota): 692 rows, by operating companies, filed since November 1, 2024, $34.60, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/minnesota
- [Form D filings in Biotechnology](https://specstream.ai/data/form-d/industry/biotechnology): 1,568 rows, by operating companies, filed since November 1, 2024, $78.40, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/biotechnology

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 13300 67th Ave N, Maple Grove, MN, 55311
- Phone: (612) 802-9299
- Industry: Biotechnology
- Entity type: Corporation
- Incorporated in: Minnesota
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1663434

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| May 15, 2020 | New notice | $10,890,965 | $100,000 | $10,790,965 | 3 | May 4, 2020 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343420000001/0001663434-20-000001-index.htm) |
| Oct 11, 2019 | New notice | $6,000,000 | $2,066,366 | $3,933,634 | 31 | Sep 27, 2019 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343419000001/0001663434-19-000001-index.htm) |
| Aug 22, 2018 | New notice | $12,000,000 | $1,428,760 | $10,571,240 | 7 | Aug 8, 2018 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343418000003/0001663434-18-000003-index.htm) |
| Jun 4, 2018 | Amendment | $6,000,000 | $4,930,000 | $1,070,000 | 64 | Oct 24, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343418000002/0001663434-18-000002-index.htm) |
| Apr 2, 2018 | Amendment | $4,500,000 | $4,390,000 | $110,000 | 48 | Oct 24, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343418000001/0001663434-18-000001-index.htm) |
| Sep 28, 2017 | New notice | $3,000,000 | $0 | $3,000,000 | 0 | Yet to occur | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343417000002/0001663434-17-000002-index.htm) |
| Mar 13, 2017 | New notice | $6,000,000 | $2,412,489 | $3,587,511 | 16 | Feb 24, 2017 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343417000001/0001663434-17-000001-index.htm) |
| Oct 3, 2016 | Amendment | $2,500,000 | $2,500,000 | $0 | 36 | Jul 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343416000003/0001663434-16-000003-index.htm) |
| Jul 26, 2016 | New notice | $1,500,000 | $523,000 | $977,000 | 8 | Jul 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343416000002/0001663434-16-000002-index.htm) |
| Jan 12, 2016 | New notice | $2,300,000 | $1,138,600 | $1,161,400 | 9 | Dec 29, 2015 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1663434/000166343416000001/0001663434-16-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Sriram Nadathur | Director |  |
| Patrick O'Shaughnessy | Director |  |
| Yung-Ping Yeh | Executive Officer, Director, Promoter |  |
| Paul Hansen | Director |  |
| Kevin Gunderson | Director |  |
| Andrew LaFrence | Executive Officer, Promoter |  |
| Robert Petcavich | Executive Officer, Director, Promoter |  |

## Other biotechnology companies in Minnesota that filed recently

- [Medical 21, Inc.](https://specstream.ai/data/form-d/company/medical-21-inc-1673688) $550,000 · Oct 23, 2026
- [InSitu Biologics, Inc.](https://specstream.ai/data/form-d/company/insitu-biologics-inc-1723443) $1.3 million · Oct 14, 2026
- [Evia Bio, Inc.](https://specstream.ai/data/form-d/company/evia-bio-inc-1954759) $5.5 million · Sep 28, 2026
- [EyeMacular Regeneration, Inc.](https://specstream.ai/data/form-d/company/eyemacular-regeneration-inc-2042485) $2.9 million · Sep 25, 2026
- [ProEncia Biotechnology Inc.](https://specstream.ai/data/form-d/company/proencia-biotechnology-inc-2103044) $1.5 million · Aug 26, 2026

[Every Form D from the week of May 11, 2020](https://specstream.ai/data/form-d/week/2020-05-11) · [All recent filings in Minnesota](https://specstream.ai/data/form-d/state/minnesota) · [All recent Biotechnology filings](https://specstream.ai/data/form-d/industry/biotechnology)

Read from SEC EDGAR. Amount sold is what StemoniX, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).